COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 1140: Articles 11391-11400  | Next

Potent antibody immunity to SARS-CoV-2 variants elicited by a third dose of inactivated vaccine
Ju, B., Zhou, B., Song, S., Fan, Q., Ge, X., Wang, H., Cheng, L., Guo, H., Shu, D., Liu, L., Zhang, Z.
10.1101/2021.11.10.468037 — Posted: 2021-11-10
LRRC15 suppresses SARS-CoV-2 infection and controls collagen production
Loo, L., Waller, M. A., Cole, A. J., Stella, A. O., Moreno, C. L., Denes, C. E., Hamoudi, Z., Chung, F., Aggarwal, A., Low, J. K. K., Patel, K., Siddique, R., Mackay, J., Turville, S., Hesselson, D., Neely, G. G.
10.1101/2021.11.09.467981 — Posted: 2021-11-10
The P681H mutation in the Spike glycoprotein confers Type I interferon resistance in the SARS-CoV-2 alpha (B.1.1.7) variant
Lista, M. J., Winstone, H., Wilson, H., Dyer, A., Pickering, S., Galao, R. P., De Lorenzo, G., Cowton, V., Furnon, W., Suarez, N. M., Orton, R., Palmarini, M., Patel, A. H., Snell, L. B., Nebbia, G., Swanson, C. M., Neil, S.
10.1101/2021.11.09.467693 — Posted: 2021-11-10
A novel histone deacetylase inhibitor-based approach to eliminate microglia and retain astrocyte properties in glial cell culture.
He, X.-B., Wu, Y., Huang, H., Guo, F.
10.1101/2021.11.09.467827 — Posted: 2021-11-10
Viral kinetic modeling and clinical trial simulation predicts disruption of respiratory disease trials by non-pharmaceutical COVID-19 interventions
Arsene, S., Couty, C., Faddeenkov, I., Go, N., Granjeon-Noriot, S., Smit, D., Kahoul, R., Illigens, B., Boissel, J.-P., Chevalier, A., Lehr, L., Pasquali, C., Kulesza, A.
10.1101/2021.11.09.21266145 — Posted: 2021-11-10
Genomic landscape of SARS-CoV-2 pandemic in Brazil suggests an external P.1 variant origin
Perico, C. P., De Pierri, C. R., Neto, G. P., Fernandes, D. R., Pedrosa, F. d. O., de Souza, E. M., Raittz, R. T.
10.1101/2021.11.10.21266084 — Posted: 2021-11-10
COVID-19 vaccinations: perceptions and behaviours in people with primary ciliary dyskinesia
Pedersen, E. S. L., Mallet, M. C., Lam, Y. T., Bellu, S., Cizeau, I., Copeland, F., Fernandez, T. L., Manion, M., Harris, A., Lucas, J. S., Santamaria, F., COVID-PCD patient advisory group, , Goutaki, M., Kuehni, C. E.
10.1101/2021.11.08.21266047 — Posted: 2021-11-10
Design of D-amino acids SARS-CoV-2 Main protease inhibitors using the cationic peptide from rattlesnake venom as a scaffold
Eberle, R. J., Gering, I., Tusche, M., Ostermann, P. N., Mueller, L., Adams, O., Schaal, H., Olivier, D. S., Amaral, M. S., Arni, R. K., Willbold, D., Coronado, M.
10.1101/2021.11.10.468025 — Posted: 2021-11-10
Characterization of the humoral immune response to BNT162b2 in elderly residents of long-term care facilities five to seven months after vaccination
Delbrueck, M., Hoehl, S., Toptan, T., Schenk, B., Grikscheit, K., Metzler, M., Herrmann, E., Ciesek, S.
10.1101/2021.11.09.21266110 — Posted: 2021-11-10
Unexposed populations and potential COVID-19 burden in European countries
Chapman, L. A. C., Barnard, R. C., Russell, T. W., Abbott, S., van Zandvoort, K., Davies, N. G., Kucharski, A. J.
10.1101/2021.11.10.21266166 — Posted: 2021-11-10 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).